Airway host-microbiome interactions in chronic obstructive pulmonary disease
Background Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). Methods We performed a longitudinal 16S ribosomal RNA gene-based microbiome survey on 101 sputum samples from 16 healthy subjects and 43 COPD patients, alo...
Saved in:
Published in | Respiratory research Vol. 20; no. 1; pp. 113 - 14 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
06.06.2019
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1465-993X 1465-9921 1465-993X |
DOI | 10.1186/s12931-019-1085-z |
Cover
Abstract | Background
Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD).
Methods
We performed a longitudinal 16S ribosomal RNA gene-based microbiome survey on 101 sputum samples from 16 healthy subjects and 43 COPD patients, along with characterization of host sputum transcriptome and proteome in COPD patients.
Results
Dysbiosis of sputum microbiome was observed with significantly increased relative abundance of
Moraxella
in COPD versus healthy subjects and during COPD exacerbations, and
Haemophilus
in COPD ex-smokers versus current smokers. Multivariate modeling on sputum microbiome, host transcriptome and proteome profiles revealed that significant associations between
Moraxella
and
Haemophilus
, host interferon and pro-inflammatory signaling pathways and neutrophilic inflammation predominated among airway host-microbiome interactions in COPD. While neutrophilia was positively correlated with
Haemophilus
, interferon signaling was more strongly linked to
Moraxella.
Moreover, while
Haemophilus
was significantly associated with host factors both in stable state and during exacerbations,
Moraxella
-associated host responses were primarily related to exacerbations.
Conclusions
Our study highlights a significant airway host-microbiome interplay associated with COPD inflammation and exacerbations. These findings indicate that
Haemophilus
and
Moraxella
influence different components of host immune response in COPD, and that novel therapeutic strategies should consider targeting these bacteria and their associated host pathways in COPD. |
---|---|
AbstractList | Background Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). Methods We performed a longitudinal 16S ribosomal RNA gene-based microbiome survey on 101 sputum samples from 16 healthy subjects and 43 COPD patients, along with characterization of host sputum transcriptome and proteome in COPD patients. Results Dysbiosis of sputum microbiome was observed with significantly increased relative abundance of Moraxella in COPD versus healthy subjects and during COPD exacerbations, and Haemophilus in COPD ex-smokers versus current smokers. Multivariate modeling on sputum microbiome, host transcriptome and proteome profiles revealed that significant associations between Moraxella and Haemophilus, host interferon and pro-inflammatory signaling pathways and neutrophilic inflammation predominated among airway host-microbiome interactions in COPD. While neutrophilia was positively correlated with Haemophilus, interferon signaling was more strongly linked to Moraxella. Moreover, while Haemophilus was significantly associated with host factors both in stable state and during exacerbations, Moraxella-associated host responses were primarily related to exacerbations. Conclusions Our study highlights a significant airway host-microbiome interplay associated with COPD inflammation and exacerbations. These findings indicate that Haemophilus and Moraxella influence different components of host immune response in COPD, and that novel therapeutic strategies should consider targeting these bacteria and their associated host pathways in COPD. Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD).BACKGROUNDLittle is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD).We performed a longitudinal 16S ribosomal RNA gene-based microbiome survey on 101 sputum samples from 16 healthy subjects and 43 COPD patients, along with characterization of host sputum transcriptome and proteome in COPD patients.METHODSWe performed a longitudinal 16S ribosomal RNA gene-based microbiome survey on 101 sputum samples from 16 healthy subjects and 43 COPD patients, along with characterization of host sputum transcriptome and proteome in COPD patients.Dysbiosis of sputum microbiome was observed with significantly increased relative abundance of Moraxella in COPD versus healthy subjects and during COPD exacerbations, and Haemophilus in COPD ex-smokers versus current smokers. Multivariate modeling on sputum microbiome, host transcriptome and proteome profiles revealed that significant associations between Moraxella and Haemophilus, host interferon and pro-inflammatory signaling pathways and neutrophilic inflammation predominated among airway host-microbiome interactions in COPD. While neutrophilia was positively correlated with Haemophilus, interferon signaling was more strongly linked to Moraxella. Moreover, while Haemophilus was significantly associated with host factors both in stable state and during exacerbations, Moraxella-associated host responses were primarily related to exacerbations.RESULTSDysbiosis of sputum microbiome was observed with significantly increased relative abundance of Moraxella in COPD versus healthy subjects and during COPD exacerbations, and Haemophilus in COPD ex-smokers versus current smokers. Multivariate modeling on sputum microbiome, host transcriptome and proteome profiles revealed that significant associations between Moraxella and Haemophilus, host interferon and pro-inflammatory signaling pathways and neutrophilic inflammation predominated among airway host-microbiome interactions in COPD. While neutrophilia was positively correlated with Haemophilus, interferon signaling was more strongly linked to Moraxella. Moreover, while Haemophilus was significantly associated with host factors both in stable state and during exacerbations, Moraxella-associated host responses were primarily related to exacerbations.Our study highlights a significant airway host-microbiome interplay associated with COPD inflammation and exacerbations. These findings indicate that Haemophilus and Moraxella influence different components of host immune response in COPD, and that novel therapeutic strategies should consider targeting these bacteria and their associated host pathways in COPD.CONCLUSIONSOur study highlights a significant airway host-microbiome interplay associated with COPD inflammation and exacerbations. These findings indicate that Haemophilus and Moraxella influence different components of host immune response in COPD, and that novel therapeutic strategies should consider targeting these bacteria and their associated host pathways in COPD. Background Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). Methods We performed a longitudinal 16S ribosomal RNA gene-based microbiome survey on 101 sputum samples from 16 healthy subjects and 43 COPD patients, along with characterization of host sputum transcriptome and proteome in COPD patients. Results Dysbiosis of sputum microbiome was observed with significantly increased relative abundance of Moraxella in COPD versus healthy subjects and during COPD exacerbations, and Haemophilus in COPD ex-smokers versus current smokers. Multivariate modeling on sputum microbiome, host transcriptome and proteome profiles revealed that significant associations between Moraxella and Haemophilus, host interferon and pro-inflammatory signaling pathways and neutrophilic inflammation predominated among airway host-microbiome interactions in COPD. While neutrophilia was positively correlated with Haemophilus, interferon signaling was more strongly linked to Moraxella. Moreover, while Haemophilus was significantly associated with host factors both in stable state and during exacerbations, Moraxella-associated host responses were primarily related to exacerbations. Conclusions Our study highlights a significant airway host-microbiome interplay associated with COPD inflammation and exacerbations. These findings indicate that Haemophilus and Moraxella influence different components of host immune response in COPD, and that novel therapeutic strategies should consider targeting these bacteria and their associated host pathways in COPD. Keywords: Chronic obstructive pulmonary disease, COPD, Microbiome, Exacerbations, Clinical study, Transcriptome, Proteome, Healthy, Smokers, Next-generation sequencing technologies Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). We performed a longitudinal 16S ribosomal RNA gene-based microbiome survey on 101 sputum samples from 16 healthy subjects and 43 COPD patients, along with characterization of host sputum transcriptome and proteome in COPD patients. Dysbiosis of sputum microbiome was observed with significantly increased relative abundance of Moraxella in COPD versus healthy subjects and during COPD exacerbations, and Haemophilus in COPD ex-smokers versus current smokers. Multivariate modeling on sputum microbiome, host transcriptome and proteome profiles revealed that significant associations between Moraxella and Haemophilus, host interferon and pro-inflammatory signaling pathways and neutrophilic inflammation predominated among airway host-microbiome interactions in COPD. While neutrophilia was positively correlated with Haemophilus, interferon signaling was more strongly linked to Moraxella. Moreover, while Haemophilus was significantly associated with host factors both in stable state and during exacerbations, Moraxella-associated host responses were primarily related to exacerbations. Our study highlights a significant airway host-microbiome interplay associated with COPD inflammation and exacerbations. These findings indicate that Haemophilus and Moraxella influence different components of host immune response in COPD, and that novel therapeutic strategies should consider targeting these bacteria and their associated host pathways in COPD. Abstract Background Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). Methods We performed a longitudinal 16S ribosomal RNA gene-based microbiome survey on 101 sputum samples from 16 healthy subjects and 43 COPD patients, along with characterization of host sputum transcriptome and proteome in COPD patients. Results Dysbiosis of sputum microbiome was observed with significantly increased relative abundance of Moraxella in COPD versus healthy subjects and during COPD exacerbations, and Haemophilus in COPD ex-smokers versus current smokers. Multivariate modeling on sputum microbiome, host transcriptome and proteome profiles revealed that significant associations between Moraxella and Haemophilus, host interferon and pro-inflammatory signaling pathways and neutrophilic inflammation predominated among airway host-microbiome interactions in COPD. While neutrophilia was positively correlated with Haemophilus, interferon signaling was more strongly linked to Moraxella. Moreover, while Haemophilus was significantly associated with host factors both in stable state and during exacerbations, Moraxella-associated host responses were primarily related to exacerbations. Conclusions Our study highlights a significant airway host-microbiome interplay associated with COPD inflammation and exacerbations. These findings indicate that Haemophilus and Moraxella influence different components of host immune response in COPD, and that novel therapeutic strategies should consider targeting these bacteria and their associated host pathways in COPD. Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). We performed a longitudinal 16S ribosomal RNA gene-based microbiome survey on 101 sputum samples from 16 healthy subjects and 43 COPD patients, along with characterization of host sputum transcriptome and proteome in COPD patients. Dysbiosis of sputum microbiome was observed with significantly increased relative abundance of Moraxella in COPD versus healthy subjects and during COPD exacerbations, and Haemophilus in COPD ex-smokers versus current smokers. Multivariate modeling on sputum microbiome, host transcriptome and proteome profiles revealed that significant associations between Moraxella and Haemophilus, host interferon and pro-inflammatory signaling pathways and neutrophilic inflammation predominated among airway host-microbiome interactions in COPD. While neutrophilia was positively correlated with Haemophilus, interferon signaling was more strongly linked to Moraxella. Moreover, while Haemophilus was significantly associated with host factors both in stable state and during exacerbations, Moraxella-associated host responses were primarily related to exacerbations. Our study highlights a significant airway host-microbiome interplay associated with COPD inflammation and exacerbations. These findings indicate that Haemophilus and Moraxella influence different components of host immune response in COPD, and that novel therapeutic strategies should consider targeting these bacteria and their associated host pathways in COPD. Background Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). Methods We performed a longitudinal 16S ribosomal RNA gene-based microbiome survey on 101 sputum samples from 16 healthy subjects and 43 COPD patients, along with characterization of host sputum transcriptome and proteome in COPD patients. Results Dysbiosis of sputum microbiome was observed with significantly increased relative abundance of Moraxella in COPD versus healthy subjects and during COPD exacerbations, and Haemophilus in COPD ex-smokers versus current smokers. Multivariate modeling on sputum microbiome, host transcriptome and proteome profiles revealed that significant associations between Moraxella and Haemophilus , host interferon and pro-inflammatory signaling pathways and neutrophilic inflammation predominated among airway host-microbiome interactions in COPD. While neutrophilia was positively correlated with Haemophilus , interferon signaling was more strongly linked to Moraxella. Moreover, while Haemophilus was significantly associated with host factors both in stable state and during exacerbations, Moraxella -associated host responses were primarily related to exacerbations. Conclusions Our study highlights a significant airway host-microbiome interplay associated with COPD inflammation and exacerbations. These findings indicate that Haemophilus and Moraxella influence different components of host immune response in COPD, and that novel therapeutic strategies should consider targeting these bacteria and their associated host pathways in COPD. |
ArticleNumber | 113 |
Audience | Academic |
Author | Maschera, Barbara Brown, James R. Michalovich, David Lea, Simon Kolsum, Umme Hessel, Edith M. Wang, Zhang Van Horn, Stephanie Traini, Christopher Singh, Dave |
Author_xml | – sequence: 1 givenname: Zhang surname: Wang fullname: Wang, Zhang organization: Computational Biology, Human Genetics, Research and Development (R&D), GlaxoSmithKline (GSK), Present Address: School of Life Sciences, South China Normal University – sequence: 2 givenname: Barbara surname: Maschera fullname: Maschera, Barbara organization: Refractory Respiratory Inflammation Discovery Performance Unit, Respiratory Therapy Area, R&D, GSK – sequence: 3 givenname: Simon surname: Lea fullname: Lea, Simon organization: University of Manchester and University Hospital of South Manchester – sequence: 4 givenname: Umme surname: Kolsum fullname: Kolsum, Umme organization: University of Manchester and University Hospital of South Manchester – sequence: 5 givenname: David surname: Michalovich fullname: Michalovich, David organization: Refractory Respiratory Inflammation Discovery Performance Unit, Respiratory Therapy Area, R&D, GSK – sequence: 6 givenname: Stephanie surname: Van Horn fullname: Van Horn, Stephanie organization: Functional Genomics, Medicinal Science and Technology, R&D, GSK – sequence: 7 givenname: Christopher surname: Traini fullname: Traini, Christopher organization: Functional Genomics, Medicinal Science and Technology, R&D, GSK – sequence: 8 givenname: James R. orcidid: 0000-0002-9368-627X surname: Brown fullname: Brown, James R. email: James.R.Brown@gsk.com organization: Computational Biology, Human Genetics, Research and Development (R&D), GlaxoSmithKline (GSK) – sequence: 9 givenname: Edith M. surname: Hessel fullname: Hessel, Edith M. organization: Refractory Respiratory Inflammation Discovery Performance Unit, Respiratory Therapy Area, R&D, GSK – sequence: 10 givenname: Dave surname: Singh fullname: Singh, Dave organization: University of Manchester and University Hospital of South Manchester |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31170986$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Uk1v1DAQjVAR_YAfwAVF4sIlxZ9xfEFaVXxUWokLSNwsx5nsepXYi50Utb-eWbYs3QqQZdkev_c8M37nxUmIAYriJSWXlDb120yZ5rQiVFeUNLK6e1KcUVHLSmv-7eTB_rQ4z3lDCFWNks-KU06pIrqpz4rlwqcf9rZcxzxVo3cptj6OUPowQbJu8jFkPJRunWLwroxtntKM8Rsot_MwxmDTbdn5DDbD8-Jpb4cML-7Xi-Lrh_dfrj5Vy88fr68Wy8rVhE-V44wLi1PrRoq2o7IT4BiVugNNa8k1dFK3UoDmDe871YLtO90pJAoqKL8orve6XbQbs01-xCRMtN78CsS0MjZN3g1gnKS25k0DtukFawGlCPZOcMEtaXuFWu_2Wtu5HaFzEKZkhyPR45vg12YVb0wtpVSiQYE39wIpfp8hT2b02cEw2ABxzoZxTpmsidrl_foRdBPnFLBVhjHBFOEcf-uAWlkswIc-4rtuJ2oWUhPFmdYMUZd_QeHoAL8RfdJ7jB8RXj0s9FDhby8ggO4BaIKcE_QHCCVm5zez95tBv5md38wdctQjjvOT3bkGs_HDf5lsz8z4SlhB-tOLf5N-AvYY6YA |
CitedBy_id | crossref_primary_10_1080_19490976_2022_2156254 crossref_primary_10_1097_MCP_0000000000000850 crossref_primary_10_2147_COPD_S357491 crossref_primary_10_1080_1040841X_2020_1830748 crossref_primary_10_1016_j_micpath_2023_106335 crossref_primary_10_2147_COPD_S371958 crossref_primary_10_3389_fmicb_2020_01758 crossref_primary_10_1111_cei_13638 crossref_primary_10_1111_jcmm_16206 crossref_primary_10_3390_cells11091416 crossref_primary_10_3390_medsci8010006 crossref_primary_10_1136_bmj_2021_065871 crossref_primary_10_1007_s12275_024_00167_4 crossref_primary_10_2217_bmm_2021_0653 crossref_primary_10_1093_jleuko_qiae153 crossref_primary_10_3389_fmicb_2024_1451160 crossref_primary_10_1042_CS20220175 crossref_primary_10_3389_fcimb_2023_1161203 crossref_primary_10_1016_j_jaci_2023_10_001 crossref_primary_10_1038_s41591_023_02424_2 crossref_primary_10_3390_biomedicines9101337 crossref_primary_10_3390_jpm13050804 crossref_primary_10_1186_s12879_020_05313_y crossref_primary_10_3389_fimmu_2024_1407439 crossref_primary_10_3390_biomedicines10051110 crossref_primary_10_1183_16000617_0084_2023 crossref_primary_10_1016_j_rmed_2020_106092 crossref_primary_10_1038_s41598_023_32901_0 crossref_primary_10_3390_ijms24032955 crossref_primary_10_3390_ijms221910872 crossref_primary_10_1111_imm_13848 crossref_primary_10_1093_jac_dkaa557 crossref_primary_10_1186_s12931_025_03113_z crossref_primary_10_1186_s12950_022_00308_9 crossref_primary_10_1186_s12931_022_02069_8 crossref_primary_10_23749_mdl_v111i6_10947 crossref_primary_10_3389_fphar_2022_1020133 crossref_primary_10_1016_j_micpath_2023_106062 crossref_primary_10_3389_fmolb_2022_839259 crossref_primary_10_1172_JCI150473 crossref_primary_10_1016_S2666_5247_21_00035_5 crossref_primary_10_1099_mgen_0_000754 crossref_primary_10_1002_INMD_20230023 crossref_primary_10_1016_j_antiviral_2025_106076 crossref_primary_10_12677_ACM_2020_106135 crossref_primary_10_1097_MCP_0000000000000834 crossref_primary_10_1111_apm_13386 crossref_primary_10_1016_j_heliyon_2024_e24775 crossref_primary_10_1183_23120541_00044_2022 crossref_primary_10_3390_jcm10132889 crossref_primary_10_1038_s41522_021_00185_9 crossref_primary_10_2147_COPD_S337181 crossref_primary_10_1038_s41467_020_19701_0 crossref_primary_10_1093_jambio_lxae089 crossref_primary_10_3390_ijms25158223 crossref_primary_10_1155_2021_9278441 crossref_primary_10_1002_imt2_33 crossref_primary_10_1007_s12016_022_08928_y crossref_primary_10_1038_s41598_021_99238_4 crossref_primary_10_3390_ijms25158467 crossref_primary_10_1186_s12931_024_02973_1 crossref_primary_10_31083_j_fbs1403023 crossref_primary_10_1183_16000617_0053_2024 crossref_primary_10_12688_f1000research_132220_4 crossref_primary_10_3389_fmicb_2022_1085079 crossref_primary_10_1016_j_ijid_2024_107274 crossref_primary_10_12688_f1000research_132220_3 crossref_primary_10_12688_f1000research_132220_2 crossref_primary_10_12688_f1000research_132220_1 crossref_primary_10_1099_mgen_0_000485 crossref_primary_10_1183_16000617_0241_2021 crossref_primary_10_3389_fcimb_2024_1386201 crossref_primary_10_1016_j_csbj_2023_10_016 crossref_primary_10_1080_14789450_2023_2265062 crossref_primary_10_3390_cells11010002 crossref_primary_10_1016_j_micres_2022_127244 crossref_primary_10_1002_cdt3_66 crossref_primary_10_4046_trd_2020_0026 crossref_primary_10_1093_jac_dkae335 crossref_primary_10_1186_s12931_021_01722_y crossref_primary_10_1183_20734735_0161_2021 crossref_primary_10_1080_17476348_2024_2355155 crossref_primary_10_1111_crj_13294 crossref_primary_10_1183_23120541_00168_2020 crossref_primary_10_1186_s12931_020_01552_4 crossref_primary_10_3389_fcimb_2024_1379831 crossref_primary_10_3390_ijms23105692 crossref_primary_10_4168_aair_2021_13_4_589 crossref_primary_10_1136_thorax_2021_217923 crossref_primary_10_1183_23120541_00595_2023 crossref_primary_10_3389_fbioe_2025_1524013 crossref_primary_10_1016_j_bioflm_2022_100096 |
Cites_doi | 10.1164/ajrccm.152.4.7551388 10.1089/omi.2009.0100 10.1378/chest.14-0764 10.7326/0003-4819-106-2-196 10.1186/s12915-014-0087-z 10.1186/s40169-015-0068-z 10.1371/journal.pone.0016384 10.1186/1741-7015-11-181 10.1093/nar/gkv007 10.1111/j.2517-6161.1995.tb02031.x 10.1080/15216540600756004 10.1016/j.immuni.2018.04.022 10.1164/ajrccm.157.5.9711044 10.1038/nmeth.f.303 10.1073/pnas.1322269111 10.1378/chest.116.1.40 10.1371/journal.pone.0047305 10.1016/S0140-6736(14)61136-3 10.1159/000330667 10.1038/mi.2017.75 10.1007/s10096-013-2044-0 10.1186/1471-2105-13-52 10.1136/thoraxjnl-2017-210408 10.1093/gerona/glu121 10.1073/pnas.0506580102 10.1152/ajplung.00449.2007 10.1136/thoraxjnl-2017-210741 10.1164/rccm.201111-2075OC 10.1378/chest.117.5_suppl_2.398S 10.1371/journal.pone.0079353 10.1371/journal.pone.0008578 10.1164/rccm.201302-0341OC 10.1164/rccm.201502-0223OC 10.1073/pnas.1507719112 10.1093/bioinformatics/btp616 10.1038/ng0506-500 10.1128/CMR.14.2.336-363.2001 10.1183/13993003.01406-2015 10.1186/1559-0275-11-32 10.1128/JCM.00035-14 10.1378/chest.108.2_Supplement.43S 10.1164/rccm.201607-1408OC 10.1186/s13059-015-0637-x 10.1186/1465-9921-14-85 10.1371/journal.pone.0068302 10.1371/journal.pone.0024457 10.18637/jss.v067.i01 10.3390/ijerph6010209 10.1164/rccm.201104-0597OC |
ContentType | Journal Article |
Copyright | The Author(s). 2019 COPYRIGHT 2019 BioMed Central Ltd. 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s). 2019 – notice: COPYRIGHT 2019 BioMed Central Ltd. – notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7U7 7U9 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BENPR C1K CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P M7N PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
DOI | 10.1186/s12931-019-1085-z |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Toxicology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals (WRLC) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Environmental Sciences and Pollution Management ProQuest Central ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts Toxicology Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1465-993X |
EndPage | 14 |
ExternalDocumentID | oai_doaj_org_article_c51a6388ea8f42bebea01184343a0bf7 PMC6555748 A590732992 31170986 10_1186_s12931_019_1085_z |
Genre | Journal Article |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GroupedDBID | --- 0R~ 29P 2WC 4.4 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX ALIPV CITATION -A0 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF FRP M~E NPM PMFND 7QL 7U7 7U9 7XB 8FK AZQEC C1K DWQXO H94 K9. M7N PKEHL PQEST PQUKI 7X8 5PM |
ID | FETCH-LOGICAL-c603t-c3234a23499854bd15d4ec2159de916539ed59b54e9383fd7beafd9d7c3241413 |
IEDL.DBID | 7X7 |
ISSN | 1465-993X 1465-9921 |
IngestDate | Wed Aug 27 01:30:59 EDT 2025 Thu Aug 21 17:55:49 EDT 2025 Thu Sep 04 17:44:49 EDT 2025 Sat Aug 23 14:58:15 EDT 2025 Tue Jun 17 21:06:51 EDT 2025 Tue Jun 10 20:42:29 EDT 2025 Thu Jan 02 22:59:50 EST 2025 Thu Apr 24 22:57:22 EDT 2025 Tue Jul 01 02:43:14 EDT 2025 Sat Sep 06 07:28:58 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Smokers Transcriptome Exacerbations Proteome Chronic obstructive pulmonary disease Next-generation sequencing technologies Healthy COPD Microbiome Clinical study |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c603t-c3234a23499854bd15d4ec2159de916539ed59b54e9383fd7beafd9d7c3241413 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-9368-627X |
OpenAccessLink | https://www.proquest.com/docview/2242703399?pq-origsite=%requestingapplication% |
PMID | 31170986 |
PQID | 2242703399 |
PQPubID | 42864 |
PageCount | 14 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_c51a6388ea8f42bebea01184343a0bf7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6555748 proquest_miscellaneous_2331256071 proquest_journals_2242703399 gale_infotracmisc_A590732992 gale_infotracacademiconefile_A590732992 pubmed_primary_31170986 crossref_primary_10_1186_s12931_019_1085_z crossref_citationtrail_10_1186_s12931_019_1085_z springer_journals_10_1186_s12931_019_1085_z |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-06-06 |
PublicationDateYYYYMMDD | 2019-06-06 |
PublicationDate_xml | – month: 06 year: 2019 text: 2019-06-06 day: 06 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Respiratory research |
PublicationTitleAbbrev | Respir Res |
PublicationTitleAlternate | Respir Res |
PublicationYear | 2019 |
Publisher | BioMed Central BioMed Central Ltd BMC |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
References | T Zakharkina (1085_CR39) 2013; 8 M Reich (1085_CR34) 2006; 38 L Millares (1085_CR10) 2014; 33 RP Dickson (1085_CR13) 2014; 384 R Rodriguez-Roisin (1085_CR19) 2000; 117 SA Shetty (1085_CR47) 2013; 8 GP DeMuri (1085_CR46) 2017 B Brindefalk (1085_CR32) 2011; 6 A Subramanian (1085_CR33) 2005; 102 PT King (1085_CR43) 2015; 4 Y Hathout (1085_CR26) 2015; 112 S Sethi (1085_CR45) 2001; 14 David Mayhew (1085_CR12) 2018; 73 MA Sze (1085_CR7) 2012; 185 A Trompette (1085_CR49) 2018; 48 DMM Bates (1085_CR30) 2015; 67 M Mofarrahi (1085_CR40) 2008; 294 NR Anthonisen (1085_CR18) 1987; 106 JR Erb-Downward (1085_CR37) 2011; 6 BL Barker (1085_CR42) 2015; 147 PV Chang (1085_CR48) 2014; 111 Zhang Wang (1085_CR11) 2017; 73 PL Molyneaux (1085_CR36) 2013; 188 X Wang (1085_CR23) 2012; 13 JA Wedzicha (1085_CR53) 2013; 11 MA Sze (1085_CR14) 2015; 192 KA BPaCR (1085_CR31) 2014 YJ Huang (1085_CR8) 2014; 52 MD Robinson (1085_CR27) 2010; 26 YJ Huang (1085_CR38) 2010; 14 HF Lu (1085_CR51) 2017; 6 M Bafadhel (1085_CR20) 2012; 83 JG Caporaso (1085_CR21) 2010; 7 AI Ivanov (1085_CR41) 2006; 58 M Bafadhel (1085_CR55) 2011; 184 ME Ritchie (1085_CR28) 2015; 43 AA Pragman (1085_CR6) 2012; 7 MR Mehan (1085_CR25) 2014; 11 Z Wang (1085_CR54) 2016; 47 SJ Salter (1085_CR22) 2014; 12 Z Wang (1085_CR9) 2016 E Klaile (1085_CR44) 2013; 14 M Hilty (1085_CR5) 2010; 5 C Menni (1085_CR24) 2015; 70 E Monso (1085_CR3) 1995; 152 International Conference on (1085_CR17) 2001; 47 R Laniado-Laborin (1085_CR52) 2009; 6 M Miravitlles (1085_CR2) 1999; 116 XC Morgan (1085_CR29) 2015; 16 PL Molyneaux (1085_CR15) 2017; 195 N Soler (1085_CR4) 1998; 157 P Ball (1085_CR1) 1995; 108 General Assembly of the World Medical A (1085_CR16) 2014; 81 Y Benjamini (1085_CR35) 1995; 57 A Cait (1085_CR50) 2018; 11 |
References_xml | – volume: 152 start-page: 1316 issue: 4 Pt 1 year: 1995 ident: 1085_CR3 publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.152.4.7551388 – volume: 14 start-page: 9 issue: 1 year: 2010 ident: 1085_CR38 publication-title: Omics doi: 10.1089/omi.2009.0100 – volume: 147 start-page: 46 issue: 1 year: 2015 ident: 1085_CR42 publication-title: Chest doi: 10.1378/chest.14-0764 – volume: 106 start-page: 196 issue: 2 year: 1987 ident: 1085_CR18 publication-title: Ann Intern Med doi: 10.7326/0003-4819-106-2-196 – volume: 12 start-page: 87 year: 2014 ident: 1085_CR22 publication-title: BMC Biol doi: 10.1186/s12915-014-0087-z – volume: 4 start-page: 68 issue: 1 year: 2015 ident: 1085_CR43 publication-title: Clin Transl Med doi: 10.1186/s40169-015-0068-z – volume: 6 start-page: e16384 issue: 2 year: 2011 ident: 1085_CR37 publication-title: PLoS One doi: 10.1371/journal.pone.0016384 – volume: 11 start-page: 181 year: 2013 ident: 1085_CR53 publication-title: BMC Med doi: 10.1186/1741-7015-11-181 – volume: 43 start-page: e47 issue: 7 year: 2015 ident: 1085_CR28 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkv007 – volume: 57 start-page: 289 year: 1995 ident: 1085_CR35 publication-title: J R Stat Soc Ser B Methodol doi: 10.1111/j.2517-6161.1995.tb02031.x – volume: 58 start-page: 389 issue: 7 year: 2006 ident: 1085_CR41 publication-title: IUBMB Life doi: 10.1080/15216540600756004 – volume: 48 start-page: 992 issue: 5 year: 2018 ident: 1085_CR49 publication-title: Immunity doi: 10.1016/j.immuni.2018.04.022 – volume: 157 start-page: 1498 issue: 5 Pt 1 year: 1998 ident: 1085_CR4 publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.157.5.9711044 – volume: 7 start-page: 335 issue: 5 year: 2010 ident: 1085_CR21 publication-title: Nat Methods doi: 10.1038/nmeth.f.303 – volume: 111 start-page: 2247 issue: 6 year: 2014 ident: 1085_CR48 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1322269111 – volume: 116 start-page: 40 issue: 1 year: 1999 ident: 1085_CR2 publication-title: Chest doi: 10.1378/chest.116.1.40 – volume-title: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America year: 2017 ident: 1085_CR46 – volume: 7 start-page: e47305 issue: 10 year: 2012 ident: 1085_CR6 publication-title: PLoS One doi: 10.1371/journal.pone.0047305 – volume: 384 start-page: 691 issue: 9944 year: 2014 ident: 1085_CR13 publication-title: Lancet doi: 10.1016/S0140-6736(14)61136-3 – volume: 83 start-page: 36 issue: 1 year: 2012 ident: 1085_CR20 publication-title: Respiration doi: 10.1159/000330667 – volume: 11 start-page: 785 issue: 3 year: 2018 ident: 1085_CR50 publication-title: Mucosal Immunol doi: 10.1038/mi.2017.75 – volume: 33 start-page: 1101 issue: 7 year: 2014 ident: 1085_CR10 publication-title: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology doi: 10.1007/s10096-013-2044-0 – volume: 13 start-page: 52 year: 2012 ident: 1085_CR23 publication-title: BMC Bioinf doi: 10.1186/1471-2105-13-52 – volume: 73 start-page: 422 issue: 5 year: 2018 ident: 1085_CR12 publication-title: Thorax doi: 10.1136/thoraxjnl-2017-210408 – volume: 70 start-page: 809 issue: 7 year: 2015 ident: 1085_CR24 publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/glu121 – volume: 102 start-page: 15545 issue: 43 year: 2005 ident: 1085_CR33 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0506580102 – volume: 294 start-page: L955 issue: 5 year: 2008 ident: 1085_CR40 publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00449.2007 – volume: 81 start-page: 14 issue: 3 year: 2014 ident: 1085_CR16 publication-title: J Am Coll Dent – volume: 73 start-page: 331 issue: 4 year: 2017 ident: 1085_CR11 publication-title: Thorax doi: 10.1136/thoraxjnl-2017-210741 – volume: 185 start-page: 1073 issue: 10 year: 2012 ident: 1085_CR7 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201111-2075OC – volume: 6 start-page: e112 issue: 12 year: 2017 ident: 1085_CR51 publication-title: Emerg Microbes Infect – volume: 117 start-page: 398S issue: 5 Suppl 2 year: 2000 ident: 1085_CR19 publication-title: Chest doi: 10.1378/chest.117.5_suppl_2.398S – volume: 8 start-page: e79353 issue: 11 year: 2013 ident: 1085_CR47 publication-title: PLoS One doi: 10.1371/journal.pone.0079353 – volume: 5 start-page: e8578 issue: 1 year: 2010 ident: 1085_CR5 publication-title: PLoS One doi: 10.1371/journal.pone.0008578 – volume: 188 start-page: 1224 issue: 10 year: 2013 ident: 1085_CR36 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201302-0341OC – volume: 192 start-page: 438 issue: 4 year: 2015 ident: 1085_CR14 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201502-0223OC – volume: 112 start-page: 7153 issue: 23 year: 2015 ident: 1085_CR26 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1507719112 – volume: 26 start-page: 139 issue: 1 year: 2010 ident: 1085_CR27 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp616 – volume: 38 start-page: 500 issue: 5 year: 2006 ident: 1085_CR34 publication-title: Nat Genet doi: 10.1038/ng0506-500 – volume: 14 start-page: 336 issue: 2 year: 2001 ident: 1085_CR45 publication-title: Clin Microbiol Rev doi: 10.1128/CMR.14.2.336-363.2001 – volume: 47 start-page: 1082 issue: 4 year: 2016 ident: 1085_CR54 publication-title: Eur Respir J doi: 10.1183/13993003.01406-2015 – volume: 11 start-page: 32 issue: 1 year: 2014 ident: 1085_CR25 publication-title: Clin Proteomics doi: 10.1186/1559-0275-11-32 – volume: 52 start-page: 2813 issue: 8 year: 2014 ident: 1085_CR8 publication-title: J Clin Microbiol doi: 10.1128/JCM.00035-14 – volume: 108 start-page: 43S issue: 2 year: 1995 ident: 1085_CR1 publication-title: Chest doi: 10.1378/chest.108.2_Supplement.43S – volume-title: Lung microbiome dynamics in chronic obstructive pulmonary disease exacerbations. The European respiratory journal year: 2016 ident: 1085_CR9 – volume: 195 start-page: 1640 issue: 12 year: 2017 ident: 1085_CR15 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201607-1408OC – volume: 16 start-page: 67 year: 2015 ident: 1085_CR29 publication-title: Genome Biol doi: 10.1186/s13059-015-0637-x – volume: 47 start-page: 45 issue: 1 year: 2001 ident: 1085_CR17 publication-title: J Postgrad Med – volume: 14 start-page: 85 year: 2013 ident: 1085_CR44 publication-title: Respir Res doi: 10.1186/1465-9921-14-85 – volume: 8 start-page: e68302 issue: 7 year: 2013 ident: 1085_CR39 publication-title: PLoS One doi: 10.1371/journal.pone.0068302 – volume-title: lmerTest: tests in linear mixed effects models year: 2014 ident: 1085_CR31 – volume: 6 start-page: e24457 issue: 9 year: 2011 ident: 1085_CR32 publication-title: PLoS One doi: 10.1371/journal.pone.0024457 – volume: 67 start-page: 1 issue: 1 year: 2015 ident: 1085_CR30 publication-title: J Stat Softw doi: 10.18637/jss.v067.i01 – volume: 6 start-page: 209 issue: 1 year: 2009 ident: 1085_CR52 publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph6010209 – volume: 184 start-page: 662 issue: 6 year: 2011 ident: 1085_CR55 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201104-0597OC |
SSID | ssj0017875 |
Score | 2.539136 |
Snippet | Background
Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD).
Methods
We... Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). We performed a... Background Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). Methods We... Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD). We performed a... Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD).BACKGROUNDLittle is known... Abstract Background Little is known about the interactions between the lung microbiome and host response in chronic obstructive pulmonary disease (COPD).... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 113 |
SubjectTerms | Aged Antibiotics Bacterial infections Care and treatment Cell adhesion & migration Chronic obstructive lung disease Chronic obstructive pulmonary disease Clinical study COPD Cytokines Development and progression Dysbacteriosis Exacerbations Female Gene expression Gene Expression Profiling - methods Haemophilus Haemophilus influenzae - genetics Health aspects Health care Host Microbial Interactions - physiology Host-bacteria relationships Humans Immune response Immune system Infectious diseases Inflammation Interferon Leukocytes (neutrophilic) Longitudinal Studies Lung - microbiology Lung - physiology Lung diseases Male Medicine Medicine & Public Health Microbiome Microbiomes Microbiota (Symbiotic organisms) Microbiota - physiology Middle Aged Moraxella Moraxella - genetics Neutrophilia Obstructive lung disease Pneumology/Respiratory System Proteomes Pulmonary Disease, Chronic Obstructive - genetics Pulmonary Disease, Chronic Obstructive - microbiology Relative abundance Respiratory tract rRNA 16S Signal transduction Signaling Smoking Sputum Sputum - microbiology Sputum - physiology Streptococcus infections Transcriptome |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals (WRLC) dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3daxQxEB-kD-KLqPVjtcoWBEFZutlNssnjKZYirU8W-hbytXjQ7pW7Vmn_emeyubNbqb74cA93Sbhk9jeZmZ3MLwBvewwqoqIgh_UYoDQSdU4FUTFr6RK7TvuG6p2PvsqDY_7lRJzcuOqLzoSN9MCj4Pa8YBYxoqJVPW8c_qelYkkqiLS161Mdea3rdTCV8wcIQ5FzmEzJvRVZNQqbdZVO219PrFAi6_9zS75hk26fl7yVNE22aP8RPMxOZDkbJ_8Y7sXhCdw_ymnybTiczZc_7VVJFRzV2XzkWjqLJXFDLMdKhhV-Kf3IjFsuXKaR_RHL88tTRKZdXpU5d_MUjvc_f_t0UOVrEyov6_ai8m3TcosfjKQEd4GJwKNH065DRGdQtDoGoZ3gUWN42ocORdoHHTocyBkatWewNSyG-ALKzln0D31ULkVSQfWCS9vX0gkWGWsLqNdiND5zitPVFqcmxRZKmlHyBiVPVKTCXBfwfjPkfCTU-Fvnj_RsNh2JCzv9gAgxGSHmXwgp4B09WUMai5PzNhce4BKJ-8rMhMZ9Ds1yU8DOpCdqmp82r7FhsqavDLpADe6a6OcVsLtpppF0em2Ii0vs07aMXMuOFfB8hNJmSS1d_aOVLKCbgGyy5mnLMP-eeMClEKLjqoAPazj-ntadIn35P0T6Ch40pEz0NkruwBZiNL5G5-zCvUl6-Asi9zTG priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwED6NISFeEL_JGChISEigQJ3Yjv2AUEFME6I8UWlvlu04o1KXjnQbdH89d4nbkTH20IfUdhRfvvPdxb7vAF7WGFQERUEOqzFAySXqnKpExqylInal9jnlO0--yf0p_3IgDrZgXd4qCnB5ZWhH9aSm7fzt75-rD6jw7zuFV_LdkmwWBcU6687Sn9-Am2iYJMViE36xqYDYFH2ykci0zlnc5LzyFgMz1bH5_7tm_2W0Lh-ovLSr2hmrvbtwJ3qZ6biHxT3YCs19uDWJ--gP4Ot41v6yq5RSPLKjWU_GdBRSIo9o-1SHJV6kvqfOTRcu8syehfT4dI7Qte0qjZs7D2G69_n7p_0s1lXIvBwVJ5kv8oJb_GGoJbirmKh48Gj7dRXQWxSFDpXQTvCgMX6tq9IFW1e6KnEgZ2j1HsF2s2jCE0hLZ9GB9EG5LtSqVC24tPVIOsECY0UCo7UYjY-k41T7Ym664ENJ00veoOSJq1SY8wReb4Yc94wb13X-SO9m05HIsrs_Fu2hibpnvGAWlxkVrKp57hC2lvJtKafWjlxdJvCK3qwhkOHDeRszE3CKRI5lxkLjQoh2O09gd9ATVdEPm9fYMGskG_SRclxW0RFM4MWmmUbS8bYmLE6xT1Ew8j1LlsDjHkqbKRVUG0grmUA5ANlgzsOWZvajIwqXQoiSqwTerOF48Vj_FenO9ZN4CrdzUhP6ECV3YRvRF56hX3binnfa9gdGwjEO priority: 102 providerName: Scholars Portal – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3daxQxEB-0gvgifru1ygqCoCxeNpts8ngWSxHrk4W-hXwtHrR75a5V2r--M9nc2q0f4MM-3GYCm-Q3mZmbzC8AbzoMKqKiIId1GKDUEnVOBVExa-kSu1b7muqdD77K_cPm85E4ymTRVAtzPX_PlPywJntEAa-u0jn5y9twRzAuU15W7o4JA8SdyEnLP3abmJ3Ezv_7HnzNCN08IHkjS5qMz94DuJ-9xnI-LPNDuBX7R3D3IOfFH8OX-WL1016UVLJRnSwGcqWTWBIZxGooXVjjj9IPVLjl0mXe2B-xPD0_Rija1UWZkzVP4HDv07fd_Srfk1B5OeNnlec1byw-GDqJxgUmQhM92nIdInp_gusYhHaiiRrj0S60Ltou6NBix4ahFXsKW_2yj8-hbJ1Fh9BH5VLoFFQnGmm7mXSCRcZ4AbPNNBqfScTpLotjk4IJJc0w8wZnnrhHhbks4N3Y5XRg0PiX8Edam1GQyK_TC8SEybpkvGAWtw0Vreqa2iEMLdXPUo2snbmuLeAtrawhFcWP8zZXGuAQiezKzIXGjQ3tcF3AzkQSVctPmzfYMFm11wZ9nhq3SXTsCng9NlNPOq7Wx-U5ynDOyJdsWQHPBiiNQ-J0149WsoB2ArLJmKct_eJ7Iv6WQoi2UQW838Dx12f9dUq3_0v6BdyrSWvofya5A1sIxvgS3a4z9yop3BUeDiTs priority: 102 providerName: Springer Nature |
Title | Airway host-microbiome interactions in chronic obstructive pulmonary disease |
URI | https://link.springer.com/article/10.1186/s12931-019-1085-z https://www.ncbi.nlm.nih.gov/pubmed/31170986 https://www.proquest.com/docview/2242703399 https://www.proquest.com/docview/2331256071 https://pubmed.ncbi.nlm.nih.gov/PMC6555748 https://doaj.org/article/c51a6388ea8f42bebea01184343a0bf7 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3_a9QwFH_oBuIv4ner86ggCErZpW3S5Ce5HRtDvaHi4H4LaZrqwdaed5uy_fW-l-Y6O3E_tNAmgSb9vLz3krzPA3hdo1PhJDk5rEYHJRUoc7LiCTOGktgVyqYU7zw7EofH-Yc5n4cFt3U4VrmZE_1EXbWW1sh3UdWkiE7Up--XPxPKGkW7qyGFxm3Y9tRliOdi3jtcDMHIu-giniiVsrCryaTYXZOeI0daJf78_eVAL3n6_n8n6b-01PUTlNe2Ub12OrgP94JZGU86HDyAW655CHdmYeP8EXyaLFa_zUVMMR3J6aJjXzp1MbFFrLrYhjU-xLbjyo3bMhDL_nLx8vwEO29WF3HYzXkMxwf736aHSUikkFgxzs4Sm6VZbvBC34rnZcV4lTuLyl5VDs1DnilXcVXy3Cl0WOuqKJ2pK1UV2DBnqOaewFbTNu4ZxEVp0GK0Tpbet6pkzXNh6rEoOXOMZRGMN8OobWAZp2QXJ9p7G1LobuQ1jjyRk3J9GcHbvsmyo9i4qfIe_Zu-IrFj-xft6rsOwqYtZwbnFemMrPO0RJwaCrClIFozLusigjf0ZzXJMH6cNSEUAbtIbFh6whXOfKio0wh2BjVR9uyweIMNHWR_ra-QGsGrvpha0nm2xrXnWCfLGBmbBYvgaQelvksZJQNSUkRQDEA26POwpFn88MzggnNe5DKCdxs4Xn3Wf4f0-c2deAF3UxITWnkSO7CF6HMv0RA7K0de2kawvbd_9PkrPk3FdOQXNfD-8YvE-yyXfwB5-zME |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgJeEN9kDAgSCAkUrU7iJH5AqINNHWsrhDZpb57jOKzSlpR2Y-r-KP5G7hInI0PsbQ99aG1X8fk-c77fAbzJMagwCQU5LMcAxY9Q5pKMe0wpamIXC-1TvfN4Eg33w68H_GAFfje1MHStstGJlaLOSk3vyDfQ1PjInWhPP81-etQ1irKrTQuNmi12zfIcQ7bFx50veL5vfX97a-_z0LNdBTwd9YNTTwd-ECr8YKDBwzRjPAuNRssnMoO-Eg-EybhIeWgERm95FqdG5ZnIYlwYMtT5-L-3YDWkitYerG5uTb59b_MWyP68rmfinhA-s3lUlkQbC7KsFLoLr7rxf9GxhFXDgH_Nwl928eqdzSuJ28oebt-He9aRdQc15z2AFVM8hNtjm6p_BKPBdH6uli5VkXgn0xrv6cS4hE8xr6spFvjF1TU6r1umFsr2l3FnZ8dIbjVfujZ_9Bj2b4TIT6BXlIV5Bm6cKvRRtUnSKprLkpyHkcr7UcqZYSxwoN-QUWqLa07tNY5lFd8kkawpL5HyBIfK5YUD79slsxrU47rJm3Q27UTC465-KOc_pBVvqTlTqMkSo5I89FOUDEUlvVS2q_ppHjvwjk5WktbAh9PKFj_gFgl_Sw64QF2LroHvwHpnJkq77g43vCGttlnIS9lw4HU7TCvpBl1hyjOcEwSM3NuYOfC0ZqV2SwG1HxJJ5EDcYbLOnrsjxfSowiKPOOdxmDjwoWHHy8f6L0nXrt_EK7gz3BuP5Ghnsvsc7vokMvTeK1qHHnKieYFu4Gn60sqeC4c3Le5_AAuBa0I |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEB-0QvFF_DZaNYIgKKG3ye5m83hWj6pt8cFC35b9Sj1oc8fdtaX9651J9qKpH-BDHpKdhf2Y2ZnJ7PwG4HWNTkVQ5OSwGh2UXKLMKS8yZgwVsSsrl1O-8_6B3D3kn4_EUaxzulzfdl-HJLucBkJpalbbc193Iq7k9pK0FLnBVdbenr-6Cbc4aT6K1sqdPoyA3ChiKPOP3QbKqMXs__1k_kU1Xb82eS122qqkyV24E23JdNxt_j24EZr7sLkfo-UPYG88XVyYy5QSObLTaQe5dBpSgohYdAkNS3xJXQeQm85sRJM9D-n87AQZ1Cwu0xjCeQiHk4_fdnazWD0hc3JUrDJX5AU3-KBDJbj1THgeHGr4yge0CUVRBS8qK3io0EutfWmDqX3lS-zIGeq2R7DRzJrwBNLSGjQTXVC2dai8qgWXph5JK1hgrEhgtF5G7SK0OFW4ONGti6Gk7lZe48oTIqnQVwm87bvMO1yNfxG_p73pCQkSu_0wWxzrKGHaCWbwMFHBqJrnFpnTUFYtZc6aka3LBN7QzmoSXBycMzH_AKdIEFh6LCo87lA75wlsDShR4Nywec0bOgr8UqMllOPhieZeAq_6ZupJl9iaMDtDmqJgZGGWLIHHHSv1UyqoAlClZALlgMkGcx62NNPvLRy4FEKUXCXwbs2OP4f11yV9-l_UL2Hz64eJ3vt08OUZ3M5JgOhHlNyCDeTL8BztspV90creDzInMCA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Airway+host-microbiome+interactions+in+chronic+obstructive+pulmonary+disease&rft.jtitle=Respiratory+research&rft.au=Zhang%2C+Wangrbara+Maschera&rft.au=Lea%2C+Simon&rft.au=Kolsum%2C+Umme&rft.au=Michalovich%2C+David&rft.date=2019-06-06&rft.pub=BioMed+Central&rft.issn=1465-9921&rft.eissn=1465-993X&rft.volume=20&rft_id=info:doi/10.1186%2Fs12931-019-1085-z |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1465-993X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1465-993X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1465-993X&client=summon |